Unknown

Dataset Information

0

PH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.


ABSTRACT: The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc variants with high affinity binding at acidic pH that vary in pH 7.4 affinities and assessed pharmacokinetic outcomes. Pharmacokinetic studies in human FcRn transgenic mice and cynomolgus monkeys showed that multiple variants with increased FcRn affinities at acidic pH exhibited extended serum half-lives relative to the parental IgG. Importantly, the results reveal an underappreciated affinity threshold of neutral pH binding that determines IgG recycling efficiency. Variants with pH 7.4 FcRn affinities below this threshold recycle efficiently and can exhibit increased serum persistence. Increasing neutral pH FcRn affinity beyond this threshold reduced serum persistence by offsetting the benefits of increased pH 6.0 binding. Ultra-high affinity binding to FcRn at both acidic and neutral pH leads to rapid serum clearance.

SUBMITTER: Borrok MJ 

PROVIDER: S-EPMC4326836 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.

Borrok M Jack MJ   Wu Yanli Y   Beyaz Nurten N   Yu Xiang-Qing XQ   Oganesyan Vaheh V   Dall'Acqua William F WF   Tsui Ping P  

The Journal of biological chemistry 20141223 7


The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc  ...[more]

Similar Datasets

| S-EPMC125858 | biostudies-literature
| S-EPMC5627591 | biostudies-literature
| S-EPMC10443974 | biostudies-literature
| S-EPMC8207189 | biostudies-literature
| S-EPMC4622529 | biostudies-literature
2008-01-01 | GSE10017 | GEO
| S-EPMC2650344 | biostudies-literature
| S-EPMC6920022 | biostudies-literature
| S-EPMC4632629 | biostudies-literature
| S-EPMC2708033 | biostudies-literature